Analysts expect over 2018 rising revenue Rhoen-Klinikum

Tomorrow the German Rhoen-Klinikum will report its past quarters results. For this year Rhoen-Klinikum 's revenue will be around 1,25 billion euros. This is according to the average of the analysts' estimates. This is slightly more than 2017's revenue of 1,21 billion euros.

Historical revenues and results Rhoen-Klinikum plus estimates 2018

equity research

The analysts expect for 2018 a net profit of 43 million euros. The majority of the analysts expects for this year a profit per share of 62 cent. The price/earnings-ratio therefore equals 35,65.

For this year most of the analysts expect a dividend of 0,28 cents per share. Thus the dividend yield equals 1,27 percent. The average dividend yield of the support companies equals a limited 1 percent.

Latest estimates around 24 euros

The most recent recommendations for the support company are from Independent Research, Deutsche Bank and Standard & Poors.

Rhoen-Klinikum 's market capitalization is based on the number of outstanding shares around 1,48 billion euros. The Rhoen-Klinikum stock was the past 12 months quite volatile. Since last November the stock is 27 percent lower. This year the stock price moved between 21 and 32 euro. Since 2008 the stock price is almost 22 percent higher.

At 11.18 the stock trades 0,45 percent higher at 22,1 euros.

Historical stock prices Rhoen-Klinikum

equity research rhoen-klinikum

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.